Parvo preventative picks up speedDecember 29, 2020Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.
SPONSORED CONTENTScience In Every StepFeel confident knowing every step a Librela (bedinvetmab injection) treated dog takes is backed by science + Learn More